Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models. | Theranostics | 2023 | 36593963 | PubTator, text mining | PubMed |
| Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity. | Pharmacol Res Perspect | 2023 | 36585794 | PubTator, text mining | PubMed |
| Challenges in the Diagnosis of Epstein-Barr Virus-positive Inflammatory Follicular Dendritic Cell Sarcoma: Extremely Wide Morphologic Spectrum and Immunophenotype. | Am J Surg Pathol | 2023 | 36574358 | PubTator, text mining | PubMed |
| Neuroendocrine tumor of the breast showing invasive micropapillary features and multiple lymph node metastases. | Cancer Rep (Hoboken) | 2023 | 36572422 | PubTator, text mining | PubMed |
| Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin. | Am J Surg Pathol | 2023 | 36543154 | PubTator, text mining | PubMed |
| Disruption of the lung-gut-brain axis is responsible for cortex damage induced by pulmonary exposure to zinc oxide nanoparticles. | Toxicology | 2023 | 36535435 | PubTator, text mining | PubMed |
| Gastroenteropancreatic Neuroendocrine Tumor Metastasis to the Heart: Evaluation of Imaging Manifestations. | Curr Probl Diagn Radiol | 2023 | 36473799 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 Activation. | Neuroendocrinology | 2023 | 36473454 | PubTator, text mining | PubMed |
| 64Cu-DOTATATE Uptake in a Pulmonary Hamartoma. | Clin Nucl Med | 2023 | 36469060 | PubTator, text mining | PubMed |
| Widespread micronodular hepatic metastases of neuroendocrine tumor detected by [68Ga]DOTATATE PET/CT. | Radiol Case Rep | 2023 | 36439918 | PubTator, text mining | PubMed |
| 225Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors. | J Nucl Med | 2023 | 36396453 | PubTator, text mining | PubMed |
| ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly. | J Clin Endocrinol Metab | 2023 | 36353760 | PubTator, text mining | PubMed |
| RISING STARS: Heterogeneity and the tumor microenvironment in neuroendocrine prostate cancer. | J Endocrinol | 2023 | 36286645 | PubTator, text mining | PubMed |
| Survivin: A Potential Marker of Resistance to Somatostatin Receptor Ligands. | J Clin Endocrinol Metab | 2023 | 36273993 | PubTator, text mining | PubMed |
| "Vascular inflammation and cardiovascular disease: review about the role of PET imaging". | Int J Cardiovasc Imaging | 2023 | 36255543 | PubTator, text mining | PubMed |
| Imaging of pediatric neuroblastoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. | Pediatr Blood Cancer | 2023 | 36184716 | PubTator, text mining | PubMed |
| Molecular basis for the selective G protein signaling of somatostatin receptors. | Nat Chem Biol | 2023 | 36138141 | PubTator, text mining | PubMed |
| Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study. | Neuroendocrinology | 2023 | 36044870 | PubTator, text mining | PubMed |
| Exposure to di (2-ethylhexyl) phthalate causes locomotor increase and anxiety-like behavior via induction of oxidative stress in brain. | Toxicol Mech Methods | 2023 | 35818324 | PubTator, text mining | PubMed |
| Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer. | Endocr Oncol | 2022 | 37435454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=38